I was recently at a lecture given by a colleague of the Yale researcher. Apparently the Yale cancer center is going to re-run most if not all of their drug tria

I was recently at a lecture given by a colleague of the Yale researcher. Apparently the Yale cancer center is going to re-run most if not all of their drug trials because of these findings. So drugs that didn’t do well during the trials may actually have some efficacy if the protocol were changed to take into account gut biomes. The work in gut biomes are having a huge impact on medicine.